Tissue Regenix Group (TRX) Competitors GBX 27.60 +1.10 (+4.15%) As of 07/11/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAGShould you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry. Tissue Regenix Group vs. Its Competitors Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals International Consolidated Airlines Group Tissue Regenix Group (LON:TRX) and Nakama Group plc (NAK.L) (LON:NAK) are both small-cap precious metals companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends. Does the media prefer TRX or NAK? In the previous week, Tissue Regenix Group's average media sentiment score of 0.00 equaled Nakama Group plc (NAK.L)'saverage media sentiment score. Company Overall Sentiment Tissue Regenix Group Neutral Nakama Group plc (NAK.L) Neutral Is TRX or NAK more profitable? Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Tissue Regenix Group-3.46% -2.87% 0.50% Nakama Group plc (NAK.L) N/A N/A N/A Do institutionals & insiders believe in TRX or NAK? 37.0% of Tissue Regenix Group shares are held by institutional investors. 47.3% of Tissue Regenix Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation & earnings, TRX or NAK? Nakama Group plc (NAK.L) has lower revenue, but higher earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTissue Regenix Group£31.98M0.78-£1.11M-£0.97-28.49Nakama Group plc (NAK.L)£8.09M0.00N/A-£0.20N/A SummaryTissue Regenix Group and Nakama Group plc (NAK.L) tied by winning 4 of the 8 factors compared between the two stocks. Get Tissue Regenix Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRX vs. The Competition Export to ExcelMetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£24.88M£129.37M£5.60B£3.00BDividend Yield4.12%3.74%5.24%5.02%P/E Ratio-28.493.4727.96150.83Price / Sales0.784,141.03429.20314,600.02Price / Cash5.7013.1937.4627.97Price / Book0.6642.088.044.59Net Income-£1.11M-£92.15M£3.18B£5.90B7 Day Performance-3.16%1.25%3.63%11.53%1 Month Performance-18.82%4.29%4.04%7.94%1 Year Performance-61.40%174.68%29.56%32.07% Tissue Regenix Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRXTissue Regenix GroupN/AGBX 27.60+4.2%N/A-60.2%£24.88M£31.98M-28.49120Gap DownHigh Trading VolumeNAKNakama Group plc (NAK.L)N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009High Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AN/AN/AN/A£0.00N/A0.0021,300Gap UpNGNational Grid2.2874 of 5 starsGBX 1,033.50+0.2%GBX 1,135+9.8%+9.0%£50.74B£25.99B16.9810High Trading VolumeWPMWheaton Precious Metals0.9001 of 5 starsGBX 6,520+1.2%GBX 7,200+10.4%+47.2%£36.61B£1.51B60.0742News CoveragePositive NewsGap UpIAGInternational Consolidated Airlines Group1.6777 of 5 starsGBX 358.80-1.0%GBX 384+7.0%+107.6%£21.20B£37.71B7.585,360News CoverageHigh Trading Volume Related Companies and Tools Related Companies NAK Competitors EGI Competitors IMG Competitors EDG Competitors MTA Competitors NGR Competitors RRS Competitors NG Competitors WPM Competitors IAG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TRX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored"I'm risking my reputation on this"Most people think you need thousands to profit from crypto. But this free book exposes how even small inves...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRX Stock Alerts